Alpine Immune Sciences Inc
F:34LA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alpine Immune Sciences Inc
F:34LA
|
US |
|
P
|
Panasonic Holdings Corp
DUS:MAT1
|
JP |
|
Trivago NV
NASDAQ:TRVG
|
DE |
|
F
|
Fuerte Metals Corp
XTSX:FMT
|
CA |
|
E
|
EBR Systems Inc
ASX:EBR
|
US |
|
Becton Dickinson and Co
NYSE:BDX
|
US |
|
M
|
Matrix Concepts Holdings Bhd
KLSE:MATRIX
|
MY |
|
Beyond Meat Inc
NASDAQ:BYND
|
US |
|
M
|
Matichon PCL
SET:MATI
|
TH |
|
S
|
Starbucks Corp
F:SRB
|
US |
|
Prakash Pipes Ltd
NSE:PPL
|
IN |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
Walmart Inc
NASDAQ:WMT
|
US |
|
CAE Inc
TSX:CAE
|
CA |
|
HAL Trust
AEX:HAL
|
MC |
|
Charles Schwab Corp
NYSE:SCHW
|
US |
|
F
|
Forgent Power Solutions, Inc
NYSE:FPS
|
US |
|
A
|
Alphamin Resources Corp
JSE:APH
|
MU |
|
Korea Electric Power Corp
KRX:015760
|
KR |
|
Rithm Capital Corp
NYSE:RITM
|
US |
|
L
|
Link Real Estate Investment Trust
OTC:LKREF
|
HK |
|
Fox Corp
NASDAQ:FOXA
|
US |
|
O'Reilly Automotive Inc
NASDAQ:ORLY
|
US |
|
E
|
EnBW Energie Baden Wuerttemberg AG
DUS:EBK
|
DE |
Bankruptcy Probability
Alpine Immune Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Alpine Immune Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
A
|
Alpine Immune Sciences Inc
F:34LA
|
3.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
379.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Alpine Immune Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Alpine Immune Sciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
